Author:
Elshaghabee Fouad M. F.,Rokana Namita,Panwar Harsh,Heller Knut J.,Schrezenmeir Jürgen
Publisher
Springer International Publishing
Reference101 articles.
1. Abu-Shanab A, Quigley EMM (2010) The role of the gut microbiota in non-alcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7:691–701. https://doi.org/10.1038/nrgastro.2010.172
2. Alisi A, Bedogni G, Baviera G, Giorgio V, Porro E, Paris C, Giammaria P, Reali L, Anania F, Nobili V (2014) Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 39(11):1276–1285
3. Aller R, De Luis DA, Izaola O, Conde R, Gonzalez Sagrado M, Primo D, De La Fuente B, Gonzalez J (2011) Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci 15:1090–1095
4. Al-Muzafar HM, Amin KA (2017a) Efficacy of functional foods mixture in improving hypercholesterolemia, inflammatory and endothelial dysfunction biomarkers-induced by high cholesterol diet. Lipid Health Dis 16:194–204. https://doi.org/10.1186/s12944-017-0585-4
5. Al-Muzafar HM, Amin KA (2017b) Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers. BMC Complement Altern Med 17(1):43. https://doi.org/10.1186/s12906-016-1540-z
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献